Evaxion A (EVAX) Cash & Equivalents (2019 - 2026)

Evaxion A (EVAX) has 8 years of Cash & Equivalents data on file, last reported at $18.4 million in Q1 2026.

• Quarterly Cash & Equivalents rose 3.35% year-over-year to $18.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $18.4 million (up 3.35% YoY) and the FY2025 annual result came in at $23.2 million, up 290.36% from the prior year.
• Cash & Equivalents slipped to $18.4 million in Q1 2026, from $23.2 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $31.4 million in Q1 2022 to a low of $11731.0 in Q1 2024.
• A 5-year average of $13.3 million and a median of $11.9 million in 2022 frame the typical range for Cash & Equivalents.
• Annual changes were most pronounced in 2024 — Cash & Equivalents slumped 99.89% — and 2025, when it soared 152001.27%.
• Tracing EVAX's Cash & Equivalents over 5 years: stood at $13.2 million in 2022, then sank by 57.65% to $5.6 million in 2023, then increased by 6.61% to $6.0 million in 2024, then jumped by 290.36% to $23.2 million in 2025, then retreated by 20.63% to $18.4 million in 2026.
• The last three Cash & Equivalents figures came in at $18.4 million (Q1 2026), $23.2 million (Q4 2025), and $10.6 million (Q3 2025), per Business Quant data.